About
OxyNov is a Canadian medical technology company based in Québec, founded in 2009 by physicians François Lellouche and Erwan L’Her. The company specializes in respiratory health, focusing on the design, development, and commercialization of advanced oxygen therapy devices. OxyNov aims to enhance respiratory care through clinical innovation. The flagship product, FreeO2, is an advanced oxygen therapy device that optimizes oxygen administration by automatically adjusting flow based on patient needs. This innovative solution addresses the limitations of traditional oxygen therapy methods, improving safety and quality of life for patients requiring oxygen support. OxyNov primarily serves hospitals and healthcare providers, including intensive care units and respiratory care specialists. Under the leadership of CEO Patrice Allibert, who has over 35 years of experience in biotechnology, OxyNov is committed to improving patient outcomes and safety. The company also offers the OxyNov Academy, a platform for medical education that provides training on oxygen therapy and the use of FreeO2.
Technologies
Keywords
Company Information
-
Employees 15
-
Founded 2009
Location
725 Boulevard Lebourgneuf, Quebec City, Quebec, Canada, G2J 0C4